Abnormalities in Dynamic Brain Activity Caused by Mild Traumatic Brain Injury Are Partially Rescued by the Cannabinoid Type-2 Receptor Inverse Agonist SMM-189

• Published in: eNeuro 2017-07, Vol.4 (4), p.ENEURO.0387-16.2017
• Main Authors: Liu, Yu, McAfee, Samuel S, Guley, Natalie M, Del Mar, Nobel, Bu, Wei, Heldt, Scott A, Honig, Marcia G, Moore, 2nd, Bob M, Reiner, Anton, Heck, Detlef H
• Format: Article
• Language: English
• Subjects: Action Potentials - drug effects; Animals; Benzophenones - therapeutic use; Brain - drug effects; Brain - pathology; Brain Concussion - drug therapy; Brain Concussion - pathology; Brain Mapping; Brain Waves - drug effects; Cannabinoid Receptor Agonists - therapeutic use; Disease Models, Animal; Electroencephalography; Male; Mice; Mice, Inbred C57BL; Neurons - drug effects; New Research; Principal Component Analysis; Receptor, Cannabinoid, CB2 - metabolism; Time Factors
• ISSN: 2373-2822; 2373-2822
• DOI: 10.1523/ENEURO.0387-16.2017

Mild traumatic brain injury (mTBI) can cause severe long-term cognitive and emotional deficits, including impaired memory, depression, and persevering fear, but the neuropathological basis of these deficits is uncertain. As medial prefrontal cortex (mPFC) and hippocampus play important roles in memory and emotion, we used multi-site, multi-electrode recordings of oscillatory neuronal activity in local field potentials (LFPs) in awake, head-fixed mice to determine if the functioning of these regions was abnormal after mTBI, using a closed-skull focal cranial blast model. We evaluated mPFC, hippocampus CA1, and primary somatosensory/visual cortical areas (S1/V1). Although mTBI did not alter the power of oscillations, it did cause increased coherence of θ (4-10 Hz) and β (10-30 Hz) oscillations within mPFC and S1/V1, reduced CA1 sharp-wave ripple (SWR)-evoked LFP activity in mPFC, downshifted SWR frequencies in CA1, and enhanced θ-γ phase-amplitude coupling (PAC) within mPFC. These abnormalities might be linked to the impaired memory, depression, and persevering fear seen after mTBI. Treatment with the cannabinoid type-2 (CB2) receptor inverse agonist SMM-189 has been shown to mitigate functional deficits and neuronal injury after mTBI in mice. We found that SMM-189 also reversed most of the observed neurophysiological abnormalities. This neurophysiological rescue is likely to stem from the previously reported reduction in neuron loss and/or the preservation of neuronal function and connectivity resulting from SMM-189 treatment, which appears to stem from the biasing of microglia from the proinflammatory M1 state to the prohealing M2 state by SMM-189.